The reason Uganda continues to defeat Ebola?
Dr Misaki Wayengera
Dr Henry Kyobe Bosa
Prof Bruce Kirenga
Prof Pauline Byakika
Prof Pontiano Kaleebu
Prof Rhoda Wanyenze
Prof Vinard Nantulya
Prof Moses Joloba
Prof Sewankambo
And many other dedicated patriots you never hear about.
Innovating on therapeutics each day, developing local diagnostics etc..
We honour you.
Through scoring and voting exercises, participants at the MILK CENTRE priority setting workshop are helping build a community-informed maternal health research agenda, contributing to future work on breastfeeding, maternal sepsis, and postpartum depression. #MaternalSepsis
MILK CENTRE Postdoc Dr. Francis Williams Ojara is leading session on defining priority criteria at the priority setting workshop in Gulu. He has guided participants through discussions on maternal mental health and postpartum depression priorities.
Dr. Constantine Loum is facilitating the priority ranking session, where participants are voting on critical issues, helping communities identify the most urgent maternal health concerns. #AtTheEquatorUG#CommunityEngagement#MILKCENTRE#WomenHealth
How do we protect and support breastfeeding during outbreaks? Todayβs session by Dr. Peter Waitt explored the intersection of maternal lactation and research in emergency contexts. #AtTheEquatorUG#MaternalHealth#Breastfeeding#OutbreakResponse
In her welcoming remarks, the IDI Community Advisory Board (CAB) chairperson Betty Kwagala shared the purpose of bringing together diverse expertise to strengthen community centered research. #AtTheEquatorUG#MarternalHealth#CommunityVoices
The #MILK_CENTRE@At_The_EQUATOR team can now celebrate! I very much look forward to the next few years of generating evidence to support the safest and most effective use of medicines in breastfeeding mothers and their infants
@IDIMakerere@NIHRglobal@wellcometrust
We are proud to share that Prof @CatrionaWaitt will be taking part in a high-level debate at the 16th International Workshop on Women & HIV. The discussion will explore whether women living with HIV should have priority access to GLP-1 therapies. #HIVWOMEN